Diabetic Corneal Neuropathy

Diabetic keratopathy (DK) is a common, but underdiagnosed, ocular complication of diabetes mellitus (DM) that has a significant economic burden. It is characterised by progressive damage of corneal nerves, due to DM-induced chronic hyperglycaemia and its associated metabolic changes. With advances i...

Full description

Bibliographic Details
Main Authors: Hassan Mansoor, Hong Chang Tan, Molly Tzu-Yu Lin, Jodhbir S. Mehta, Yu-Chi Liu
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/9/12/3956
id doaj-4c085f5e397c429fb381461578aa6964
record_format Article
spelling doaj-4c085f5e397c429fb381461578aa69642020-12-07T00:01:56ZengMDPI AGJournal of Clinical Medicine2077-03832020-12-0193956395610.3390/jcm9123956Diabetic Corneal NeuropathyHassan Mansoor0Hong Chang Tan1Molly Tzu-Yu Lin2Jodhbir S. Mehta3Yu-Chi Liu4Al Shifa Trust Eye Hospital, Rawalpindi 44000, PakistanDepartment of Endocrinology, Singapore General Hospital, Singapore 169608, SingaporeTissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore 169856, SingaporeTissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore 169856, SingaporeTissue Engineering and Cell Therapy Group, Singapore Eye Research Institute, Singapore 169856, SingaporeDiabetic keratopathy (DK) is a common, but underdiagnosed, ocular complication of diabetes mellitus (DM) that has a significant economic burden. It is characterised by progressive damage of corneal nerves, due to DM-induced chronic hyperglycaemia and its associated metabolic changes. With advances in corneal nerve imaging and quantitative analytic tools, studies have shown that the severity of diabetic corneal neuropathy correlates with the status of diabetic peripheral neuropathy. The corneal nerve plexus is, therefore, considered as an important surrogate marker of diabetic peripheral neuropathy and helps in the evaluation of interventional efficacy in the management of DM. The clinical manifestations of DK depend on the disease severity and vary from decreased corneal sensitivity to sight-threatening corneal infections and neurotrophic ulcers. The severity of diabetic corneal neuropathy and resultant DK determines its management plan, and a step-wise approach is generally suggested. Future work would focus on the exploration of biomarkers for diabetic corneal neuropathy, the development of new treatment for corneal nerve protection, and the improvement in the clinical assessment, as well as current imaging technique and analysis, to help clinicians detect diabetic corneal neuropathy earlier and monitor the sub-clinical progression more reliably.https://www.mdpi.com/2077-0383/9/12/3956corneal nervesdiabetic keratopathydiabetes mellitusdiabetic neuropathyneurotrophic keratopathy
collection DOAJ
language English
format Article
sources DOAJ
author Hassan Mansoor
Hong Chang Tan
Molly Tzu-Yu Lin
Jodhbir S. Mehta
Yu-Chi Liu
spellingShingle Hassan Mansoor
Hong Chang Tan
Molly Tzu-Yu Lin
Jodhbir S. Mehta
Yu-Chi Liu
Diabetic Corneal Neuropathy
Journal of Clinical Medicine
corneal nerves
diabetic keratopathy
diabetes mellitus
diabetic neuropathy
neurotrophic keratopathy
author_facet Hassan Mansoor
Hong Chang Tan
Molly Tzu-Yu Lin
Jodhbir S. Mehta
Yu-Chi Liu
author_sort Hassan Mansoor
title Diabetic Corneal Neuropathy
title_short Diabetic Corneal Neuropathy
title_full Diabetic Corneal Neuropathy
title_fullStr Diabetic Corneal Neuropathy
title_full_unstemmed Diabetic Corneal Neuropathy
title_sort diabetic corneal neuropathy
publisher MDPI AG
series Journal of Clinical Medicine
issn 2077-0383
publishDate 2020-12-01
description Diabetic keratopathy (DK) is a common, but underdiagnosed, ocular complication of diabetes mellitus (DM) that has a significant economic burden. It is characterised by progressive damage of corneal nerves, due to DM-induced chronic hyperglycaemia and its associated metabolic changes. With advances in corneal nerve imaging and quantitative analytic tools, studies have shown that the severity of diabetic corneal neuropathy correlates with the status of diabetic peripheral neuropathy. The corneal nerve plexus is, therefore, considered as an important surrogate marker of diabetic peripheral neuropathy and helps in the evaluation of interventional efficacy in the management of DM. The clinical manifestations of DK depend on the disease severity and vary from decreased corneal sensitivity to sight-threatening corneal infections and neurotrophic ulcers. The severity of diabetic corneal neuropathy and resultant DK determines its management plan, and a step-wise approach is generally suggested. Future work would focus on the exploration of biomarkers for diabetic corneal neuropathy, the development of new treatment for corneal nerve protection, and the improvement in the clinical assessment, as well as current imaging technique and analysis, to help clinicians detect diabetic corneal neuropathy earlier and monitor the sub-clinical progression more reliably.
topic corneal nerves
diabetic keratopathy
diabetes mellitus
diabetic neuropathy
neurotrophic keratopathy
url https://www.mdpi.com/2077-0383/9/12/3956
work_keys_str_mv AT hassanmansoor diabeticcornealneuropathy
AT hongchangtan diabeticcornealneuropathy
AT mollytzuyulin diabeticcornealneuropathy
AT jodhbirsmehta diabeticcornealneuropathy
AT yuchiliu diabeticcornealneuropathy
_version_ 1724398161805443072